Sermonix Pharmaceuticals’ Phase 2 Lasofoxifene Trial Poster Receives a GRASP Advocate Choice Award, Selected for Post-ASCO Patient Advocate Investigator Discussions
June 08, 2022 10:00 ET
|
Sermonix Pharmaceuticals Inc.
Guiding Researchers and Advocates to Scientific Partnerships (GRASP) launched in 2019 to unite patient advocates, physicians and researchers through meaningful discussions of cancer-related...
Breast Cancer Society of Canada Grants $350,000 To Precision Oncology Research
May 25, 2022 09:24 ET
|
The Breast Cancer Society of Canada
SARNIA, Ontario, May 25, 2022 (GLOBE NEWSWIRE) -- The Breast Cancer Society of Canada (BCSC) today announced the recipients of their first-ever Breast Cancer Research request for proposals....
Sermonix Announces Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
April 28, 2022 12:47 ET
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, April 28, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...
Sermonix Pharmaceuticals Announces Poster Presentation at the 2021 San Antonio Breast Cancer Symposium
December 13, 2021 10:00 ET
|
Sermonix Pharmaceuticals LLC
COLUMBUS, Ohio, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...
Dress for the Cause this October for Life Saving Breast Cancer Research
September 14, 2021 13:00 ET
|
The Breast Cancer Society of Canada
SARNIA, Ontario, Sept. 14, 2021 (GLOBE NEWSWIRE) -- The Breast Cancer Society of Canada (BCSC) today announced its annual Dress for the Cause campaign as well as the addition of their new ‘Pin Your...
Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Preclinical Lasofoxifene Study in Endocrine-Resistant Breast Cancer
May 17, 2021 10:19 ET
|
Sermonix Pharmaceuticals LLC
Paper highlights the ability of lasofoxifene to inhibit primary tumor growth and reduce metastases in mouse models, both as monotherapy and in combination with palbociclibStudy results demonstrate...
Join the One Billion Steps Challenge and STEP UP for Breast Cancer Research
March 30, 2021 10:00 ET
|
The Breast Cancer Society of Canada
SARNIA, Ontario, March 30, 2021 (GLOBE NEWSWIRE) -- The Breast Cancer Society of Canada (BCSC) announced today the 30th anniversary of their annual Mother’s Day Walk, now the One Billion Steps...
Dress Up Your Life This October For Breast Cancer Research, Presented by Cleo
September 08, 2020 14:00 ET
|
The Breast Cancer Society of Canada
SARNIA, Ontario, Sept. 08, 2020 (GLOBE NEWSWIRE) -- The Breast Cancer Society of Canada (BCSC) announced today their 2020 Dress for the Cause campaign. During the month of October, Breast Cancer...
Care For a Cure Announces Linda Jo Thornberg, President of the Pittsburgh Business Show, Will Host the Inaugural Black Tie and Bourbon Gala 2019
November 19, 2019 13:18 ET
|
Care for a Cure
Washington Township, PA, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Care for a Cure announces Linda Jo Thornberg, President of the Pittsburgh Business Show, has been chosen to host the inaugural Black Tie...
CrownBio Licenses Translational Breast Cancer Models of Resistance and Metastasis
September 18, 2018 08:00 ET
|
Crown Bioscience
SAN DIEGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...